The idea that a single-celled bacterium can defend itself against viruses in a similar way as the 1.8-trillion-cell human ...

The idea that a single-celled bacterium can defend itself against viruses in a similar way as the 1.8-trillion-cell human immune system is still “mind-blowing” for molecular biologist Joshua Modell of ...

In May, a historic moment in science and medicine was captured in a single photo that circulated across news outlets ...

Innovative genetic engineering strategies are transforming crops, enabling them to withstand extreme climate conditions and ...

Twisted graphene precisely aligned with gold nanodisks and coupled with CRISPR achieves attomolar detection of cancer ...

If you have been staring at CRISPR Therapeutics stock lately, wondering whether it is time to buy, hold, or rethink your position, you are far from alone. Over the past week, the stock has surged 16.1 ...

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...

As investors crowd into AI names at record highs, these three healthcare stocks offer more compelling valuations.

Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a potential best-in-class profile--The AATD ...

Some viruses, known as bacteriophages, only infect bacterial cells, often destroying those bacteria in the process. Bacteriophages or phages .. | Microbiology ...

As CRISPR continues to drive breakthroughs in medicine, agriculture, and synthetic biology, understanding its origins does more than tell an ancient story. It provides a blueprint for engineering the ...